Nasus Pharma Ltd (NSRX) Deferred Tax Assets, Operating Loss Carryforwards

Nasus Pharma Ltd Deferred Tax Assets, Operating Loss Carryforwards

Nasus Pharma Ltd (NSRX) had Deferred Tax Assets, Operating Loss Carryforwards of $2.95 million as of 2025-12-31, per its 20-F filed 2026-03-25.

Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25

• 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.95M.
• 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.26M.